Suppr超能文献

针对非住院患者的药剂师服务。

Pharmacist services for non-hospitalised patients.

作者信息

de Barra Mícheál, Scott Claire L, Scott Neil W, Johnston Marie, de Bruin Marijn, Nkansah Nancy, Bond Christine M, Matheson Catriona I, Rackow Pamela, Williams A Jess, Watson Margaret C

机构信息

Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.

出版信息

Cochrane Database Syst Rev. 2018 Sep 4;9(9):CD013102. doi: 10.1002/14651858.CD013102.

Abstract

BACKGROUND

This review focuses on non-dispensing services from pharmacists, i.e. pharmacists in community, primary or ambulatory-care settings, to non-hospitalised patients, and is an update of a previously-published Cochrane Review.

OBJECTIVES

To examine the effect of pharmacists' non-dispensing services on non-hospitalised patient outcomes.

SEARCH METHODS

We searched CENTRAL, MEDLINE, Embase, two other databases and two trial registers in March 2015, together with reference checking and contact with study authors to identify additional studies. We included non-English language publications. We ran top-up searches in January 2018 and have added potentially eligible studies to 'Studies awaiting classification'.

SELECTION CRITERIA

Randomised trials of pharmacist services compared with the delivery of usual care or equivalent/similar services with the same objective delivered by other health professionals.

DATA COLLECTION AND ANALYSIS

We used standard methodological procedures of Cochrane and the Effective Practice and Organisation of Care Group. Two review authors independently checked studies for inclusion, extracted data and assessed risks of bias. We evaluated the overall certainty of evidence using GRADE.

MAIN RESULTS

We included 116 trials comprising 111 trials (39,729 participants) comparing pharmacist interventions with usual care and five trials (2122 participants) comparing pharmacist services with services from other healthcare professionals. Of the 116 trials, 76 were included in meta-analyses. The 40 remaining trials were not included in the meta-analyses because they each reported unique outcome measures which could not be combined. Most trials targeted chronic conditions and were conducted in a range of settings, mostly community pharmacies and hospital outpatient clinics, and were mainly but not exclusively conducted in high-income countries. Most trials had a low risk of reporting bias and about 25%-30% were at high risk of bias for performance, detection, and attrition. Selection bias was unclear for about half of the included studies.Compared with usual care, we are uncertain whether pharmacist services reduce the percentage of patients outside the glycated haemoglobin target range (5 trials, N = 558, odds ratio (OR) 0.29, 95% confidence interval (CI) 0.04 to 2.22; very low-certainty evidence). Pharmacist services may reduce the percentage of patients whose blood pressure is outside the target range (18 trials, N = 4107, OR 0.40, 95% CI 0.29 to 0.55; low-certainty evidence) and probably lead to little or no difference in hospital attendance or admissions (14 trials, N = 3631, OR 0.85, 95% CI 0.65 to 1.11; moderate-certainty evidence). Pharmacist services may make little or no difference to adverse drug effects (3 trials, N = 590, OR 1.65, 95% CI 0.84 to 3.24) and may slightly improve physical functioning (7 trials, N = 1329, mean difference (MD) 5.84, 95% CI 1.21 to 10.48; low-certainty evidence). Pharmacist services may make little or no difference to mortality (9 trials, N = 1980, OR 0.79, 95% CI 0.56 to 1.12, low-certaintly evidence).Of the five studies that compared services delivered by pharmacists with other health professionals, no studies evaluated the impact of the intervention on the percentage of patients outside blood pressure or glycated haemoglobin target range, hospital attendance and admission, adverse drug effects, or physical functioning.

AUTHORS' CONCLUSIONS: The results demonstrate that pharmacist services have varying effects on patient outcomes compared with usual care. We found no studies comparing services delivered by pharmacists with other healthcare professionals that evaluated the impact of the intervention on the six main outcome measures. The results need to be interpreted cautiously because there was major heterogeneity in study populations, types of interventions delivered and reported outcomes.There was considerable heterogeneity within many of the meta-analyses, as well as considerable variation in the risks of bias.

摘要

背景

本综述聚焦于药剂师提供的非配药服务,即社区、基层或门诊护理机构中的药剂师为非住院患者提供的服务,是对之前发表的Cochrane综述的更新。

目的

探讨药剂师的非配药服务对非住院患者结局的影响。

检索方法

我们于2015年3月检索了Cochrane中心对照试验注册库(CENTRAL)、医学期刊数据库(MEDLINE)、荷兰医学文摘数据库(Embase)以及另外两个数据库和两个试验注册库,并通过参考文献核对及与研究作者联系以识别其他研究。我们纳入了非英语语言出版物。我们于2018年1月进行了补充检索,并将潜在符合条件的研究添加到“待分类研究”中。

选择标准

将药剂师服务与常规护理或其他卫生专业人员提供的具有相同目标的等效/类似服务进行比较的随机试验。

数据收集与分析

我们采用了Cochrane协作网以及有效实践与医疗组织小组的标准方法程序。两名综述作者独立检查研究是否符合纳入标准、提取数据并评估偏倚风险。我们使用GRADE评估证据的总体确定性。

主要结果

我们纳入了116项试验,其中111项试验(39729名参与者)比较了药剂师干预与常规护理,5项试验(2122名参与者)比较了药剂师服务与其他医疗保健专业人员的服务。在这116项试验中,76项被纳入荟萃分析。其余40项试验未纳入荟萃分析,因为它们各自报告的独特结局指标无法合并。大多数试验针对慢性病,在一系列场所进行,主要是社区药房和医院门诊诊所,并且主要但不限于在高收入国家开展。大多数试验报告偏倚风险较低,约25%-30%在实施、检测和失访方面存在高偏倚风险。约一半纳入研究的选择偏倚尚不清楚。与常规护理相比,我们不确定药剂师服务是否能降低糖化血红蛋白未达目标范围的患者百分比(5项试验,N = 558,比值比(OR)0.29,95%置信区间(CI)0.04至2.22;极低确定性证据)。药剂师服务可能降低血压未达目标范围的患者百分比(18项试验,N = 4107,OR 0.40,95% CI 0.29至0.55;低确定性证据),并且可能在就诊或住院方面导致几乎没有差异(14项试验,N = 3631,OR 0.85,95% CI 0.65至1.11;中等确定性证据)。药剂师服务可能对药物不良反应几乎没有影响(3项试验,N = 590,OR 1.

相似文献

1
Pharmacist services for non-hospitalised patients.
Cochrane Database Syst Rev. 2018 Sep 4;9(9):CD013102. doi: 10.1002/14651858.CD013102.
2
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
Cochrane Database Syst Rev. 2021 Nov 26;11(11):CD013307. doi: 10.1002/14651858.CD013307.pub3.
3
Reducing medication errors for adults in hospital settings.
Cochrane Database Syst Rev. 2021 Nov 25;11(11):CD009985. doi: 10.1002/14651858.CD009985.pub2.
4
Shared decision-making interventions for people with mental health conditions.
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
5
Interventions to improve the appropriate use of polypharmacy for older people.
Cochrane Database Syst Rev. 2018 Sep 3;9(9):CD008165. doi: 10.1002/14651858.CD008165.pub4.
6
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
7
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
8
Interventions to prevent obesity in children aged 2 to 4 years old.
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015326. doi: 10.1002/14651858.CD015326.pub2.
9
Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards.
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD005529. doi: 10.1002/14651858.CD005529.pub3.
10
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.

引用本文的文献

1
Evaluating and Expanding Rural Victorian Community Pharmacists Role in Providing Oral Healthcare.
Aust J Rural Health. 2025 Jun;33(3):e70059. doi: 10.1111/ajr.70059.
2
The role of pharmacists in enhancing epilepsy care: a systematic review of community and outpatient interventions.
J Pharm Policy Pract. 2025 Apr 10;18(1):2487046. doi: 10.1080/20523211.2025.2487046. eCollection 2025.
4
Pharmacy Customers' Attitudes Towards Expanded Pharmacy Services in Croatia.
Pharmacy (Basel). 2024 Dec 31;13(1):2. doi: 10.3390/pharmacy13010002.
5
Intervention description of pharmacist-facilitated medication reviews in Nordic primary care settings: a scoping review.
Scand J Prim Health Care. 2025 Mar;43(1):241-253. doi: 10.1080/02813432.2024.2439909. Epub 2024 Dec 27.
6
Ablation Depth-Dependent Survival Analysis of Phototherapeutic Keratectomy for Recurrent Corneal Erosion Syndrome.
Ophthalmol Ther. 2025 Jan;14(1):141-152. doi: 10.1007/s40123-024-01070-2. Epub 2024 Nov 22.
7
Professional pharmacy Services' outcomes performance measurement: A narrative review.
Explor Res Clin Soc Pharm. 2024 Oct 23;16:100533. doi: 10.1016/j.rcsop.2024.100533. eCollection 2024 Dec.
8
Residents Preferences for Pharmacist-Managed Clinic in China: A Discrete Choice Experiment.
Patient Prefer Adherence. 2024 Jul 3;18:1409-1422. doi: 10.2147/PPA.S457655. eCollection 2024.
10
Evidence-Based Pharmaceutical Care in Community Pharmacies: A Survey of 595 French Pharmacists.
Pharmacy (Basel). 2023 Oct 7;11(5):161. doi: 10.3390/pharmacy11050161.

本文引用的文献

2
The Impact of Pharmaceutical Care Intervention on the Quality of Life of Nigerian Patients Receiving Treatment for Type 2 Diabetes.
Value Health Reg Issues. 2013 Sep-Oct;2(2):240-247. doi: 10.1016/j.vhri.2013.06.007. Epub 2013 Aug 8.
3
Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial.
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):231-241. doi: 10.2215/CJN.06790617. Epub 2018 Jan 2.
7
Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan.
Int J Clin Pharm. 2018 Feb;40(1):48-55. doi: 10.1007/s11096-017-0550-3. Epub 2017 Nov 14.
9
The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study.
Pharm Pract (Granada). 2017 Jul-Sep;15(3):1026. doi: 10.18549/PharmPract.2017.03.1026. Epub 2017 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验